Search results
Results from the WOW.Com Content Network
Anthrax vaccines are vaccines to prevent the livestock and human disease anthrax, caused by the bacterium Bacillus anthracis. [1]They have had a prominent place in the history of medicine, from Pasteur's pioneering 19th-century work with cattle (the first effective bacterial vaccine and the second effective vaccine ever) to the controversial late 20th century use of a modern product to protect ...
Anthrax can be transmitted between livestock, wildlife, and humans. ... are given antibiotics to prevent an infection. There is a vaccine for anthrax that protects against the disease, but it is ...
Anthrax meningoencephalitis is also nearly always fatal. [72] Gastrointestinal anthrax infections can be treated, but usually result in fatality rates of 25% to 60%, depending upon how soon treatment commences. Injection anthrax is the rarest form of anthrax, and has only been seen to have occurred in a group of heroin injecting drug users. [70]
The symptoms in anthrax depend on the type of infection and can take anywhere from 1 day to more than 2 months to appear. All types of anthrax have the potential, if untreated, to spread throughout the body and cause severe illness and even death. [24] Four forms of human anthrax disease are recognized based on their portal of entry.
Anthrax weaponization is the development and deployment of the bacterium Bacillus anthracis or, more commonly, its spore (referred to as anthrax), as a biological weapon. As a biological weapon, anthrax has been used in biowarfare and bioterrorism since 1914. [ 1 ]
He stated further that biological containment measures where Ivins worked were inadequate to prevent Anthrax spores from floating out of the laboratory into animal cages and offices. "You'd have had dead animals or dead people," Heine said. [142]
A pulmonary anthrax infection starts with ordinary influenza-like symptoms and progresses to a lethal hemorrhagic mediastinitis within 3–7 days, with a fatality rate that is 90% or higher in untreated patients. [85] Finally, friendly personnel and civilians can be protected with suitable antibiotics.
Raxibacumab [2] is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax.Its efficacy has been proven in rabbits and monkeys. [3] In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax ...